Inhibikase Therapeutics (IKT) Payables (2020 - 2026)
Inhibikase Therapeutics' Payables came in at $991,720 for Q2 2026, down 63.3% from $2.7 million a year earlier and down 37.5% from the prior quarter.
Powered by 
Analysis
Inhibikase Therapeutics (IKT) Payables (2020 - 2026) Analysis & Trends
At the end of FY2025, Inhibikase Therapeutics' Payables was $1.16 million, up 22.8% from FY2024.
- Payables carries a five-year compound annual growth rate of -8.1% (FY2020 to FY2025).
- Going back by year, Payables was $943,019 in FY2024 (+45.8%), $646,767 in FY2023 (-43.8%), $1.15 million in FY2022 (-14.0%) and $1.34 million in FY2021 (-24.1%).
- The five-year range for quarterly Payables is $620,528 (Q3 2025) to $21.76 million (Q1 2023).
- Year-over-year, Payables increased in three of the last eight quarters, with an average decline of 15.4%.
- The fastest year-over-year change in Payables over five years came in Q3 2022 (growth of 666.4%), and the weakest in Q3 2023 (a decline of 90.5%).
- Business Quant data shows IKT's Payables at $1.59 million (Q1 2026), $1.16 million (Q4 2025) and $620,528 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 20.92 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 5.96 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 7.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Inhibikase Therapeutics | 357.87 Mn | -227.60 Mn | - | 991,720.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 991,720.00 |
| Mar 31, 2026 | 1.59 Mn |
| Dec 31, 2025 | 1.16 Mn |
| Sep 30, 2025 | 620,528.00 |
| Jun 30, 2025 | 2.70 Mn |
| Mar 31, 2025 | 1.69 Mn |
| Dec 31, 2024 | 943,019.00 |
| Sep 30, 2024 | 2.53 Mn |
| Jun 30, 2024 | 3.38 Mn |
| Mar 31, 2024 | 3.80 Mn |
| Dec 31, 2023 | 646,767.00 |
| Sep 30, 2023 | 1.97 Mn |
| Jun 30, 2023 | 19.03 Mn |
| Mar 31, 2023 | 21.76 Mn |
| Dec 31, 2022 | 1.15 Mn |
| Sep 30, 2022 | 20.75 Mn |
| Jun 30, 2022 | 4.49 Mn |
| Mar 31, 2022 | 4.38 Mn |
| Dec 31, 2021 | 1.34 Mn |
| Sep 30, 2021 | 2.71 Mn |
API Access
Inhibikase Therapeutics Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=IKT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "IKT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=IKT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();